跳转至内容
Merck
CN
  • HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells.

Frontiers in pharmacology (2018-01-13)
Wen-Tsung Huang, Yu-Hsuan Tsai, Shang-Hung Chen, Ching-Wen Kuo, Yao-Lung Kuo, Kuo-Ting Lee, Wen-Chung Chen, Pei Chih Wu, Chun-Yu Chuang, Siao Muk Cheng, Chun-Hui Lin, Euphemia Yee Leung, Yung-Chieh Chang, Chun Hei Antonio Cheung
摘要

Intrinsic or acquired resistance to hormone therapy is frequently reported in estrogen receptor positive (ER

材料
产品编号
品牌
产品描述

Roche
不含EDTA的cOmplete Mini蛋白酶抑制剂混合物, Tablets provided in EASYpacks
Sigma-Aldrich
CelLytic M, Cell Lysis Reagent, Suitable for Mammalian cell lysis and protein solubilization.
Sigma-Aldrich
抗肌动蛋白抗体,克隆C4, ascites fluid, clone C4, Chemicon®
Sigma-Aldrich
抗Sp1抗体, Upstate®, from rabbit
Sigma-Aldrich
MISSION® esiRNA, targeting human HDAC2
Sigma-Aldrich
Anti-ATG5 Antibody, clone 177.19, clone 177.19, from mouse